Taiwan
· Delayed Price · Currency is TWD Locus Cell Statistics
Total Valuation
Locus Cell has a market cap or net worth of TWD 4.34 billion. The enterprise value is 3.27 billion.
| Market Cap | 4.34B |
| Enterprise Value | 3.27B |
Important Dates
The last earnings date was Friday, April 11, 2025.
| Earnings Date | Apr 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Locus Cell has 200.00 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 200.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.70% |
| Owned by Institutions (%) | 0.02% |
| Float | 72.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,842.11 |
| PB Ratio | 2.52 |
| P/TBV Ratio | 2.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -28.92 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.96 |
Financial Position
The company has a current ratio of 31.01, with a Debt / Equity ratio of 0.04.
| Current Ratio | 31.01 |
| Quick Ratio | 29.98 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.13 |
| Interest Coverage | -132.41 |
Financial Efficiency
Return on equity (ROE) is -6.37% and return on invested capital (ROIC) is -5.36%.
| Return on Equity (ROE) | -6.37% |
| Return on Assets (ROA) | -5.30% |
| Return on Invested Capital (ROIC) | -5.36% |
| Return on Capital Employed (ROCE) | -8.89% |
| Revenue Per Employee | 44,453 |
| Profits Per Employee | -2.13M |
| Employee Count | 53 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 0.42 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.30% in the last 52 weeks. The beta is 0.63, so Locus Cell's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | -25.30% |
| 50-Day Moving Average | 21.17 |
| 200-Day Moving Average | 24.60 |
| Relative Strength Index (RSI) | 50.19 |
| Average Volume (20 Days) | 401,259 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Locus Cell had revenue of TWD 2.36 million and -113.02 million in losses. Loss per share was -0.57.
| Revenue | 2.36M |
| Gross Profit | 1.67M |
| Operating Income | -158.37M |
| Pretax Income | -113.02M |
| Net Income | -113.02M |
| EBITDA | -149.21M |
| EBIT | -158.37M |
| Loss Per Share | -0.57 |
Balance Sheet
The company has 1.14 billion in cash and 69.33 million in debt, giving a net cash position of 1.07 billion or 5.36 per share.
| Cash & Cash Equivalents | 1.14B |
| Total Debt | 69.33M |
| Net Cash | 1.07B |
| Net Cash Per Share | 5.36 |
| Equity (Book Value) | 1.72B |
| Book Value Per Share | 8.61 |
| Working Capital | 1.15B |
Cash Flow
In the last 12 months, operating cash flow was -105.88 million and capital expenditures -442.38 million, giving a free cash flow of -548.26 million.
| Operating Cash Flow | -105.88M |
| Capital Expenditures | -442.38M |
| Free Cash Flow | -548.26M |
| FCF Per Share | -2.74 |
Margins
| Gross Margin | 70.88% |
| Operating Margin | -6,721.77% |
| Pretax Margin | -4,796.99% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Locus Cell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -2.60% |
| FCF Yield | -12.63% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Locus Cell has an Altman Z-Score of 35.01.
| Altman Z-Score | 35.01 |
| Piotroski F-Score | n/a |